[ASAP] Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer

TOC Graphic

Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.3c01476

Source link

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts